Suprachoroidal Prosthesis (44-channel)

suprachoroidal

affiliated consortiumBionic Vision Australia

Commercial Partner Bionic Vision Technologies

Early Feasibility

WarningWarningThis profile has not been verified yet. Information presented here may thus be incomplete or inaccurate.WarningWarning

The 44 Channel Suprachoroidal Retinal Prosthesis is a second generation device boasting a higher electrode array and larger field of view than the first generation device launched by Bionic Vision Technologies. Since launching a 4-patient clinical trial in 2018, the results have indicated that the device offers functional benefits to patients while providing a safe and reproducible surgical procedure.

Implant Timeline

  • 1st Implantee

Device Specifications

  • Number of electrodes: 44

Clinical Trials